Anaesthesia For Non-Obstetric Surgery During Pregnancy: Review Article
Anaesthesia For Non-Obstetric Surgery During Pregnancy: Review Article
Anaesthesia For Non-Obstetric Surgery During Pregnancy: Review Article
192]
Review Article
the anaesthesiologist must consider the effects of the Table 1: The key anaesthetic concerns for non‑obstetric
disease process itself, inhibit uterine contractions and surgery during pregnancy
avoid preterm labour and delivery. The key anaesthetic Anaesthetic concern Brief description
Maternal safety Physiological changes of pregnancy
concerns may be summarised as given in Table 1.
Conditions compelling surgery
during pregnancy
Maternal safety Foetal safety Placental transfer of drugs
According to American College of Obstetricians and Issue of teratogenicity
Gynecologists’ Committee on Obstetric Practice, Timing of exposure
regardless of trimester, pregnant woman should not Duration/dosage of exposure
be denied indicated surgery. The choice of anaesthetic FDA pregnancy category
Individual anaesthetic drugs
technique(s), and the selection of appropriate drugs of
Maternal factors leading to foetal
anaesthesia should be guided by maternal indications compromise
for surgery and the location of the surgical procedure. Maternal hypoxia
Resuscitation, if required, should be vigorously Maternal hyper/hypocarbia
performed following the standard advanced life Changes in uterine blood flow
Avoidance and/or treatment of Identification
support or advanced trauma life support protocols,
preterm labour and delivery Management
with the addition of left lateral tilt to avoid supine FDA – Food and Drug Administration
hypotension.
Placental transfer of drugs
Rapid-sequence intravenous induction and intubation, The placental drug transfer depends on various
with effective cricoid pressure, should be preceded by factors. High lipid solubility allows the rapid transfer,
meticulous pre-oxygenation with 100% oxygen for but may result in trapping of the drug in the placenta.
5 min. However, in cases of failed intubation, laryngeal Protein binding has a variable effect depending on the
mask airway has been used to ventilate successfully particular drug and protein interaction.
and safely in the reverse Trendelenburg’s position for
brief periods. As changes in maternal position can The drugs crossing placenta may be categorised into
have profound haemodynamic effects, positioning three types. In type 1 (e.g., thiopental), complete
during anaesthesia should be carried out slowly. transfer occurs with equilibrating concentrations in
maternal and foetal blood. In type 2 (e.g., ketamine),
The effects of light general anaesthesia and its the drug reaches a higher concentration in
associated catecholamine surge with resulting foetal blood compared to maternal blood. In
impaired uteroplacental perfusion are considerably type 3 (e.g., succinylcholine), only minimal amount
more dangerous to foetus. Positive pressure ventilation reaches the foetal blood.
should be used with care and end-tidal carbon dioxide
levels should be maintained within the limits. Since The mechanism of placental drug transfer may be
there is a good correlation between end-tidal CO2 (i) simple diffusion e.g., paracetamol, midazolam;
(ETCO2) and PaCO2 in pregnancy, ETCO2 can be used (ii) facilitated diffusion e.g., glucocorticoids,
to guide ventilation in pregnant patients.[6] Patients cephalosporins; (iii) active transport e.g., dopamine,
should be extubated fully awake as the risk of aspiration norepinephrine; or (iv) pinocytosis. Table 2 depicts
persists until protective airway reflexes have returned. the commonly used drugs and their placental transfer
characteristics.
Foetal safety
Depending on the dose administered, the timing of Issue of teratogenicity
exposure with respect to development, and the route A teratogen is defined as a substance that causes
of administration of any drug given during pregnancy an increase in the incidence of a particular defect
can potentially jeopardise the development of the in a foetus that cannot be attributed to chance. The
foetus. Until date, no anaesthetic drug has been proven teratogen must be given in a sufficient dose for a
to be clearly hazardous to the human foetus. It may substantial period of time at a critical developmental
be noted that no animal model perfectly simulates point to produce the defect.
human gestation and a randomised trial on pregnant
patients in this regard would be definitely unethical. When considering the possible teratogenicity of
Hence, definitive evidence seems elusive. various anaesthetic agents, several important points
Page no. 17
[Downloaded free from http://www.ijaweb.org on Monday, April 15, 2019, IP: 114.125.124.192]
must be kept in mind. First, the background incidence Food and drug administration pregnancy risk
of congenital anomalies in humans is approximately categories
3%. Second, physiologic derangements such as The Food and Drug Administration (FDA) final rule
hypoxaemia, hypercarbia, stress and hypotension may requires the removal of the pregnancy categories A,
be teratogenic themselves. These problems can occur B, C, D and X from all human prescription drug and
during anaesthesia and surgery and sometimes exist biological product labelling.[14] The new regulation
pre-operatively. requires that the labeling includes a summary of the
risks of using a drug during pregnancy and lactation,
As early as 1960s, Tuchmann-Duplessis[12] observed a discussion of the data supporting that summary, and
that major congenital malformations were most relevant information to help health care providers
likely to occur from exposures between 2 weeks make prescribing decisions and counsel women about
and 2 months of gestation. During the first 15 days the use of drugs during pregnancy and lactation.
of human gestation, the embryo is typically
aborted or preserved fully intact (an all-or-nothing FDA appeals healthcare professionals to continue
phenomenon). Among the multitude of case–control to follow the existing recommendations in
studies, rather than excess birth defects, most have current drug labels regarding the use of analgesics
shown a small increase in the risk of miscarriage or during pregnancy. Current drug labels state that
preterm delivery.[1,5,13] pregnant women should not use non-steroidal anti-
inflammatory drugs (NSAIDs) in their third trimester Maternal factors linked to foetal compromise
of pregnancy because of the risk of premature closure Since autoregulation is absent for the uteroplacental
of the ductus arteriosus in the foetus. FDA evaluated circulation, any reduction in maternal arterial
research studies published in the medical literature pressure can compromise uteroplacental blood flow
and determined they are too limited to make any leading to foetal ischaemia. Therefore, except under
recommendations at this time. unusual circumstances such as severe maternal
cardiac or renal disease, the intravenous fluid
Teratogenicity of common anaesthetic drugs administration can be liberal. Both ephedrine and
N2O inhibits methionine synthetase, an enzyme phenylephrine are currently considered safe and
necessary for DNA synthesis. Teratogenic effects effective vasopressors during pregnancy for control of
are shown in animals after administering high maternal hypotension.[21]
concentrations for prolonged periods.[15] However,
such high required doses are not encountered in Because foetal haemoglobin has a high affinity for
clinical practice. However, some recommend avoiding oxygen, transient decreases in maternal oxygenation
nitrous oxide in pregnant women.[16,17] In modern day are well tolerated by the foetus.[22] However,
practice, it is rarely necessary to use nitrous oxide in a prolonged or significant maternal hypoxaemia leads
pregnant patient, and we have so many alternatives for to uteroplacental vasoconstriction, reduced perfusion
general anaesthesia. and subsequent in foetal hypoxaemia, acidosis, and
death.[23] Maternal hypercarbia also can produce
General anaesthetic drugs inhibit synaptic uterine artery vasoconstriction compromising uterine
transmission and may lead to abnormal synaptic blood flow.[24] It can also directly lead to foetal
connections and inappropriate apoptosis.[18] Many respiratory acidosis. Similarly, hypocapnoea causes
anaesthetic agents have effects on neuronal receptors reduced uterine blood flow and can eventually trigger
which are necessary for neuronal differentiation, foetal acidosis. Uterine hypertension, as occurs
synaptogenesis, and survival during development. In with increased uterine irritability, can also lead to a
humans, the phase of rapid synaptogenesis extends reduction in the uteroplacental blood flow.
from mid-gestation to several years after birth, and
most of the perinatal anaesthetic exposure will be Risk of preterm labour
only for a brief fraction of the susceptible phase. There Many studies have reported an increased incidence
is no definite evidence to show the teratogenicity of of spontaneous abortion, premature labour, and
any volatile anaesthetic. However, it is prudent to use preterm delivery after non-obstetric surgery during
the lowest effective concentrations for the shortest pregnancy. This may be attributed to the surgery
possible time, especially because many of these drugs itself, manipulation of the uterus, or the underlying
do cause significant maternal hypotension. condition of the patient, mainly sepsis. As early as
1977, one study showed that foetal mortality was 8.7%
Benzodiazepine use in pregnancy has been associated when appendicitis occurred without perforation, but
with cleft palate and cardiac anomalies. However, was 35.7% when peritonitis was present.[25] The lowest
many recent controlled studies have countered this risk for preterm labour is reported during the second
association.[19,20] It is usually recommended to avoid trimester and for surgeries that do not manipulate the
benzodiazepine use throughout gestation and most uterus.[26]
especially during the first trimester. However, it may
be appropriate to provide judicious pre-operative When premature labour occurs, tocolytics are
anxiolysis so as to avoid increases in circulating indicated to preserve the pregnancy. Although its
catecholamine levels, which impair uteroplacental efficacy during non-obstetric surgery is debatable,
perfusion. prophylactic tocolytics may be considered in the
third trimester for lower abdominal or pelvic surgery
Most other anaesthetic medications, including for inflammatory conditions. Volatile anaesthetic
barbiturates, propofol, opioids, muscle relaxants, agents may help relaxing the uterus, although high
and local anaesthetics have been widely used during concentrations can cause undesirable hypotension.
pregnancy with a good safety record. Nonetheless, Other alternatives include, but not limited to,
delicate associations cannot be ruled out. β-mimetics (e.g., terbutaline), magnesium sulphate,
Page no. 19
[Downloaded free from http://www.ijaweb.org on Monday, April 15, 2019, IP: 114.125.124.192]
vasodilators (e.g., GTN) and calcium-channel blockers pregnant patients. Laboratory and other testing should
(e.g., nifedipine). be performed as indicated by the patient’s comorbidities
and the proposed surgery. In addition to standard
DECISION-MAKING ALGORITHM FOR NON- pre-operative procedures, preparation of pregnant
OBSTETRIC SURGERY DURING PREGNANCY women takes into account risks of aspiration, difficult
intubation, thromboembolism, and the well-being of
Elective surgery should be delayed until as late as 6 weeks the foetus. Standard adult fasting guidelines, i.e., 6–8 h
postpartum. This will allow resolution of physiological for solid food, depending on the type of food ingested
changes of pregnancy. An overall miscarriage rate (e.g., fat content) are applicable to these patients.
following surgery is reported as 5.8%, increasing to • Aspiration prophylaxis: The gastric emptying
10.5% during the first trimester.[27] A multidisciplinary has recently been shown to be normal during
team-involving surgeons, anaesthesiologists, pregnancy until the onset of labour. However,
obstetricians and perinatologists should be involved in the risk of aspiration is still higher due to
the decision on proceeding with surgery. The second reduced gastric barrier pressure and lower
trimester is chosen for semi-elective surgery, which oesophageal sphincter tone (a progesterone
cannot be postponed. Urgent surgery should not be effect).[28] The presence of additional risk
delayed because secondary complications may increase for regurgitation and aspiration, including
the risk to the mother and/or foetus. Greater risk of active reflux or obesity should be surveyed.
uterine irritability and preterm labour are encountered Prophylaxis against aspiration pneumonitis
in the advanced stages of pregnancy. This is believed should be administered from 16 weeks
to result from the direct manipulation of the uterus gestation with H2-receptor antagonists and
during surgery or the disease process itself, as there is non-particulate antacids.
no evidence to suggest that any anaesthetic technique, • Antibiotic prophylaxis: The need for antibiotic
agent or dose influences this risk. Conditions associated prophylaxis depends on the specific procedure.
with a particularly high risk include lower abdominal However, attention should be paid in selecting
and pelvic inflammatory conditions, such as acute antibiotics with good safety profile in pregnancy.
appendicitis with peritonitis. Figure 1 summarises the • Prophylactic glucocorticoids: Administration of a
decision-making algorithm in this regard. course of antenatal glucocorticoids 24–48 h before
surgery between 24 and 34 weeks of gestation can
GENERAL PRINCIPLES OF ANAESTHESIA
reduce perinatal morbidity/mortality if preterm
MANAGEMENT
birth occurs. Despite the potential benefits to the
Pre-operative preparation foetus, however, antenatal glucocorticoids are
Pregnant patients who require surgery should be best avoided in the setting of systemic infection
evaluated pre-operatively in the same manner as non- (such as sepsis or a ruptured appendix), because
they may impair the ability of the maternal
immune system to contain the infection.
• Thromboprophylaxis: Pregnancy is a
hypercoagulable state. The 2012 American
College of Chest Physicians clinical practice
guideline on prevention and treatment of
thrombosis recommends mechanical or
pharmacologic thromboprophylaxis for all
pregnant patients undergoing surgery.[29]
• Prophylactic tocolytics: There is no proven
benefit to routine administration of prophylactic
perioperative tocolytic therapy. Minimising
uterine manipulation may reduce the risk
of development of uterine contractions and
preterm labour. Tocolytics are indicated for the
treatment of preterm labour until resolution of
Figure 1: Decision-making algorithm for non-obstetric surgery during the underlying, self-limited condition that may
pregnancy have caused the contractions.
238 Indian Journal of Anaesthesia | Vol. 60 | Issue 4 | Apr 2016
Page no. 20
[Downloaded free from http://www.ijaweb.org on Monday, April 15, 2019, IP: 114.125.124.192]
Page no. 21
[Downloaded free from http://www.ijaweb.org on Monday, April 15, 2019, IP: 114.125.124.192]
11. Kan RE, Hughes SC, Rosen MA, Kessin C, Preston PG, Lobo EP. response to hypoxia. Am J Obstet Gynecol 1969;103:138-57.
Intravenous remifentanil: Placental transfer, maternal and 24. Walker AM, Oakes GK, Ehrenkranz R, McLaughlin M,
neonatal effects. Anesthesiology 1998;88:1467-74. Chez RA. Effects of hypercapnia on uterine and umbilical
12. Tuchmann-Duplessis H. The teratogenic risk. Am J Ind Med circulations in conscious pregnant sheep. J Appl Physiol
1983;4:245-58. 1976;41(5 Pt 1):727-33.
13. Shnider SM, Webster GM. Maternal and fetal hazards of 25. Babaknia A, Parsa H, Woodruff JD. Appendicitis during
surgery during pregnancy. Am J Obstet Gynecol 1965;92:891- pregnancy. Obstet Gynecol 1977;50:40-4.
900. 26. Saunders P, Milton PJ. Laparotomy during pregnancy: An
14. Available from: https://www.federalregister.gov/ assessment of diagnostic accuracy and fetal wastage. Br Med J
articles/2014/12/04/2014-28241/content-and-format-of- 1973;3:165-7.
labeling-for-human-prescription-drug-and-biological- 27. Cohen-Kerem R, Railton C, Oren D, Lishner M,
products-requirements-for?utm_campaign=email+a+friend Koren G. Pregnancy outcome following non-obstetric surgical
and utm_medium=email and utm_source=federalregister. intervention. Am J Surg 2005;190:467-73.
gov. [Last accessed on 2015 Nov 14]. 28. Wong CA, McCarthy RJ, Fitzgerald PC, Raikoff K, Avram MJ.
15. Fujinaga M, Baden JM. Methionine prevents nitrous oxide- Gastric emptying of water in obese pregnant women at term.
induced teratogenicity in rat embryos grown in culture. Anesth Analg 2007;105:751-5.
Anesthesiology 1994;81:184-9. 29. Guyatt GH, Akl EA, Crowther M, Gutterman DD,
16. Aldridge LM, Tunstall ME. Nitrous oxide and the fetus. Schuünemann HJ. American College of Chest Physicians
A review and the results of a retrospective study of 175 cases Antithrombotic Therapy and Prevention of Thrombosis Panel.
of anaesthesia for insertion of Shirodkar suture. Br J Anaesth Executive summary: Antithrombotic Therapy and Prevention
1986;58:1348-56. of Thrombosis, 9th ed: American College of Chest Physicians
17. Crawford JS, Lewis M. Nitrous oxide in early human pregnancy. Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2
Anaesthesia 1986;41:900-5. Suppl):7S-47S. doi: 10.1378/chest.1412S3
18. Sonner JM, Antognini JF, Dutton RC, Flood P, Gray AT, 30. Oats JN, Vasey DP, Waldron BA. Effects of ketamine on the
Harris RA, et al. Inhaled anaesthetics and immobility: pregnant uterus. Br J Anaesth 1979;51:1163-6.
Mechanisms, mysteries, and minimum alveolar anesthetic 31. Yoo KY, Lee JC, Yoon MH, Shin MH, Kim SJ, Kim YH, et al. The
concentration. Anesth Analg 2003;97:718-40. effects of volatile anaesthetics on spontaneous contractility
19. Safra MJ, Oakley GP Jr. Association between cleft lip with of isolated human pregnant uterine muscle: A comparison
or without cleft palate and prenatal exposure to diazepam. among sevoflurane, desflurane, isoflurane, and halothane.
Lancet 1975;2:478-80. Anesth Analg 2006;103:443-7.
20. Rosenberg L, Mitchell AA, Parsells JL, Pashayan H, Louik C, 32. Jadon A, Bagai R. Blood transfusion practices in obstetric
Shapiro S. Lack of relation of oral clefts to diazepam use during anaesthesia. Indian J Anaesth 2014;58:629-36.
pregnancy. N Engl J Med 1983;309:1282-5. 33. Garcia PJ, Olutoye OO, Ivey RT, Olutoye OA. Case scenario:
21. Ngan Kee WD, Khaw KS. Vasopressors in obstetrics: What Anesthesia for maternal-fetal surgery: The ex utero
should we be using? Curr Opin Anesthesiol 2006;19:238-43. intrapartum therapy (EXIT) procedure. Anesthesiology
22. Itskovitz J, LaGamma EF, Rudolph AM. The effect of reducing 2011;114:1446-52.
umbilical blood flow on fetal oxygenation. Am J Obstet 34. George RB, Melnick AH, Rose EC, Habib AS. Case series:
Gynecol 1983;145:813-8. Combined spinal epidural anesthesia for Cesarean delivery
23. Dilts PV Jr., Brinkman CR 3rd, Kirschbaum TH, Assali NS. and ex utero intrapartum treatment procedure. Can J Anaesth
Uterine and systemic hemodynamic interrelationships and their 2007;54:218-22.
Page no. 23